North America
International Markets
North America
Toggle North America
International Markets
Toggle International Markets
Europe
Toggle Europe
Cost-effectiveness Study of miRview™ Mets in Patients With Cancer of Unknown Primary Site
- Study Title
- Cost-effectiveness Study of miRviewג„¢ Mets in Patients With Cancer of Unknown Primary (CUP)
- Teva Identifier
- ONCO1miRviewmets
- ClinicalTrials.gov Identifier
- NCT01202786
- Study Status
- Completed
- Trial Condition(s)
- Neoplasms, Unknown Primary
Study Description
Please refer to ClinicalTrials.gov for a description of the trial
Key Participation Requirements
- Gender
- Female, Male
- Age group
- Adult, Older Adult
- Age Range
- 18 Years and older
- Trial Duration
- 05/01/2010 - 04/01/2012
